| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |